Elevated hydroperoxide levels and antioxidant patterns in Papillon-Lefèvre syndrome

Journal of Periodontology

Volumn 72, Issue 12, 2001, Pages 1760-1766

  Battino, Maurizio ^a   Ferreiro, Maria Soledad ^a   Bompadre, Stefano ^a   Leone, Luciana ^a   Mosca, Fabrizio ^a   Bullon, Pedro ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Antioxidants; Coenzyme Q; Gentathione; Hyperkeratosis pathogenesis; Papillon Lef vre syndrome; Periodontitis pathogenesis; Reactive oxygen species; Uric acid; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; GLUTATHIONE; LIPID HYDROPEROXIDE; REACTIVE OXYGEN METABOLITE; UBIDECARENONE; URIC ACID;

ARTICLE; CASE REPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; HETEROZYGOSITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERKERATOSIS; KERATOSIS PALMOPLANTARIS; MALE; OXIDATIVE STRESS; PATHOGENESIS; PERIODONTITIS; PHENOTYPE; PRESCHOOL CHILD; REFERENCE VALUE; SPECTROPHOTOMETRY;

ADULT; ANTIOXIDANTS; CHILD, PRESCHOOL; FEMALE; GLUTATHIONE; HUMANS; LIPID PEROXIDES; MALE; OXIDATIVE STRESS; PAPILLON-LEFEVRE DISEASE; PEDIGREE; PEROXIDES; UBIQUINONE; URIC ACID; VITAMIN E;

EID: 0035694027     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2001.72.12.1760     Document Type: Article

References (53)

1. Two cases of symmetrical, familial (Melada's malady) palmar and plantar keratosis of brother and sister. Coexistence in two cases with serious dental changes
2. The syndrome of palmar-plantar hyperkeratosis and premature periodontal destruction of the teeth
3. Localisation of a gene for Papillon-Lefèvre syndrome to chromosome 11q14-q21 by homozygosity mapping
4. Sublocalization of the Papillon-Lefèvre syndrome locus on 11q14-q21
5. Mutations of the cathepsin C gene are responsible for Papillon-Lefèvre syndrome
6. Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis
7. Haim-Munk syndrome and Papillon-Lefèvre syndrome are allelic mutations in cathepsin C
8. Localisation of a gene for prepubertal periodontitis to chromosome 11q14 and identification of a cathepsin C gene mutation
9. Identification of cathepsin C mutations in ethnically diverse Papillon-Lefèvre syndrome patients
10. Evidence of a founder effect for four cathepsin C gene mutations in Papillon-Lefèvre syndrome patients
11. Human dipeptidyl-peptidase I
12. Reactive oxygen species and antioxidants in inflammatory diseases
13. Oxidative injury and inflammatory periodontal diseases: The challenge of antioxidants to free radicals and reactive oxygen species
14. Periodontal disease mechanisms. Reactive oxygen species: A potential role in the pathogenesis of periodontal diseases
15. Neutrophil chemiluminescence in response to Fusobacterium nucleatum
16. Oxidative and nonoxidative killing of Actinobacillus actinomycetemcomitans by human neutrophils
17. Killing of Actinobacillus actinomycetemcomitans by the human neutrophil myeloperoxidase-hydrogen peroxide-chloride system
18. The neutrophil: Mechanisms of controlling periodontal bacteria
19. Superoxide formation and chemiluminescence of peripheral polymorphonuclear leukocytes in rapidly progressive periodontitis
20. Priming effect of P. gingivalis lipopolysaccharide on superoxide production by neutrophils from healthy and rapidly progressive periodontitis subjects
21. Role of superoxide dismutase in the physiology of P. gingivalis
22. Peroxidative extent and coenzyme Q levels in the rat: Influence of physical training and dietary fats
23. Oxidative stress induced by exercise and dietary fat modulates the coenzyme Q and vitamin A balance between plasma and mitochondria
24. Reduction of collagen degradation in experimental granulation tissue by vitamin E and selenium
25. Factors for progression of periodontal diseases
26. Local delivery of liposome-encapsulated superoxide dismutase and catalase suppress periodontal inflammation in beagles
27. Late onset Papillon-Lefèvre syndrome? A chromosomic, neutrophil function and microbiological study
28. Oxidant-antioxidant imbalance in blood of children with juvenile rheumatoid arthritis
29. Excessive free radical generation in the blood of children suffering from asthma
30. Serume beta-carotene, vitamins A and E, selenium, and the risk of lung cancer
31. 10, vitamin E and peroxidation in rat synaptic and non-synaptic occipital cerebral cortex mitochondria during aging
32. Determination of cefazolim in human serum by high performance liquid chromatography with o-line solid phase extraction
33. On-line solid-phase extraction of cephalosporins
34. Natural distribution and occurrence of Coenzyme Q homologues in mammals
35. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine
36. Measurement of antioxidants in human blood plasma
37. Altered plasma cytokines and total glutathione levels in parenterally fed critically ill trauma patients with adjuvant recombinant human growth hormone (rhGH) therapy
38. Redox state of glutathione in human plasma
39. Free radicals in inflammation: Second messengers and mediators of tissue destruction
40. Lipid peroxidation and its role in atherosclerosis
41. Effect of percutaneous absorption of fluocinolone acetonide on the activity of superoxide dismutase and total antioxidant status in patients with psoriasis
42. A clinical trial of antioxidant supplements in the treatment of oral leukoplakia
43. Use of antioxidant supplements in the treatment of human oral leukoplakia
44. Vitamin A and E blood levels in erythrodermic and pustular psoriasis associated with chronic alcoholism
45. Antioxidant enzymes in psoriatic fibroblasts and erythrocytes
46. Free radical scavenging activity of coenzyme Q measured by a chemiluminescent assay
47. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol
48. Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling
49. A role for reduced coenzyme Q in atherosclerosis?
50. Brain and skeletal muscle bioenergetic failure in familial hypobetalipoproteinemia
51. Overview of the use of CoQ10 in cardiovascular disease
52. Manifestation of heterozygosity in Papillon-Lefèvre syndrome?